In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Of the hepatic cell lines developed for in vitro studies of hepatic functions as alternatives to primary human hepatocytes, many have lost major liver-like functions, but not HepaRG cells. The increasing use of the latter worldwide raises the need for establishing the reference functional status of early biobanked HepaRG cells. Using deep proteome and secretome analyses, the levels of master regulators of the hepatic phenotype and of the structural elements ensuring biliary polarity were found to be close to those in primary hepatocytes. HepaRG cells proved to be highly differentiated, with functional mitochondria, hepatokine secretion abilities, and an adequate response to insulin. Among differences between primary human hepatocytes and HepaRG cells, the factors that possibly support HepaRG transdifferentiation properties are discussed. The HepaRG cell system thus appears as a robust surrogate for primary hepatocytes, which is versatile enough to study not only xenobiotic detoxification, but also the control of hepatic energy metabolism, secretory function and disease-related mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002
A “Proteomic Ruler” for Protein Copy Number and Concentration Estimation without Spike-in Standards
Wiśniewski, J. R., Hein, M. Y., Cox, J., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.037309 · Cited by 690 · cited 1×
“We intentionally did not use the recently described “histone ruler” [23], because of “atypical” DNA contents in these cell types, since PHH are partially multinuclear [24] and the other two cell types showed abnormal karyotypes (see the main text), potentially leading to biases in copy number estimations.”
MethodMilo, R. (2013) · BioEssays · doi:10.1002/bies.201300066 · Cited by 614 · cited 1×
“In addition, the total calculated numbers of protein molecules per cell (Table S2) were in good concordance with theoretical calculations, based on well-established cellular parameters [35].”
ResultThe role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500 · cited 1×
“Several hepatokines, which are essential to energy metabolism [63], were also well-secreted by HepaRG cells (Figure 5C).”
BackgroundLeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology
Russell, J. O., & Monga, S. P. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044010 · Cited by 471
Liver zonation: Novel aspects of its regulation and its impact on homeostasis
Gebhardt, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8491 · Cited by 275
Bell, C. C., Lauschke, V. M., Vorrink, S. U., Palmgren, H., Duffin, R., Andersson, T. B., & Ingelman-Sundberg, M. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074369 · Cited by 201 · cited 2×
“Altogether, these results were in good agreement with previous studies that used biochemical or molecular biology methods to describe the metabolic potential of HepaRG cells [11,56,57].”
BackgroundResultWiśniewski, J. R., Vildhede, A., Norén, A., & Artursson, P. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.01.016 · Cited by 185 · cited 2×
“To better characterize the proteome of the HepaRG cells, we next compared our dataset to those produced previously for HepG2 and PHH cells [5].”
MethodResult
Research works printed but not linked: 54
- Nagaki, 2008, Transcription factor HNF and hepatocyte differentiation, Hepatol Res., 38, 961, 10.1111/j.1872-034X.2008.00367.x · DOI
- Guillouzo, 2010, General review on in vitro hepatocyte models and their applications, Methods Mol. Biol., 640, 1, 10.1007/978-1-60761-688-7_1 · DOI · Paper page
- Godoy, 2016, Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue, Arch. Toxicol., 90, 2513, 10.1007/s00204-016-1761-4 · DOI · Paper page
- Vildhede, 2015, Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure, J. Proteome Res., 14, 3305, 10.1021/acs.jproteome.5b00334 · DOI · Paper page
- Rogue, 2012, Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells, Drug Metab. Dispos., 40, 151, 10.1124/dmd.111.042028 · DOI
- Andersson, 2012, The HepaRG cell line: A unique in vitro tool for understanding drug metabolism and toxicology in human, Expert Opin. Drug Metab. Toxicol., 8, 909, 10.1517/17425255.2012.685159 · DOI · Paper page
- Cerec, 2007, Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, 45, 957, 10.1002/hep.21536 · DOI · Paper page
- Smith, 2018, Differential impacts of individual and combined exposures of deoxynivalenol and zearalenone on the HepaRG human hepatic cell proteome, J. Proteom., 173, 89, 10.1016/j.jprot.2017.11.025 · DOI
- Gripon, 2002, Infection of a human hepatoma cell line by hepatitis B virus, Proc. Natl. Acad. Sci. USA, 99, 15655, 10.1073/pnas.232137699 · DOI · Paper page
- Wisniewski, 2014, Multi-enzyme digestion FASP and the ‘Total Protein Approach’-based absolute quantification of the Escherichia coli proteome, J. Proteom., 109, 322, 10.1016/j.jprot.2014.07.012 · DOI · Paper page
- Klein, 2014, Long-term maintenance of HepaRG cells in serum-free conditions and application in a repeated dose study, J. Appl. Toxicol., 34, 1078, 10.1002/jat.2929 · DOI · Paper page
- Plumel, 2016, Differential proteomics reveals age-dependent liver oxidative costs of innate immune activation in mice, J. Proteom., 135, 181, 10.1016/j.jprot.2015.09.008 · DOI
- Cox, 2011, Andromeda: A peptide search engine integrated into the MaxQuant environment, J Proteome Res., 10, 1794, 10.1021/pr101065j · DOI · Paper page
- Carapito, 2014, MSDA, a proteomics software suite for in-depth Mass Spectrometry Data Analysis using grid computing, Proteomics, 14, 1014, 10.1002/pmic.201300415 · DOI
- Vizcaino, 2016, 2016 update of the PRIDE database and its related tools, Nucleic Acids Res., 44, D447, 10.1093/nar/gkv1145 · DOI · Paper page
- Chawade, 2014, Normalyzer: A tool for rapid evaluation of normalization methods for omics data sets, J Proteome Res., 13, 3114, 10.1021/pr401264n · DOI · Paper page
- Duncan, 2013, Aneuploidy, polyploidy and ploidy reversal in the liver, Semin. Cell Dev. Biol., 24, 347, 10.1016/j.semcdb.2013.01.003 · DOI · Paper page
- Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038/nmeth.2089 · DOI · Paper page
- Cox, J., and Mann, M. (2012). 1D and 2D annotation enrichment: A statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinform., 13. · DOI · Paper page
- Pham, 2010, On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics, Bioinformatics, 26, 363, 10.1093/bioinformatics/btp677 · DOI · Paper page
- Jackson, 2016, Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures, Drug Metab. Dispos., 44, 1463, 10.1124/dmd.116.069831 · DOI
- Knowles, 1980, Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science, 209, 497, 10.1126/science.6248960 · DOI · Paper page
- Cheung, 2009, Hep G2 is a hepatoblastoma-derived cell line, Hum. Pathol., 40, 1512, 10.1016/j.humpath.2009.07.003 · DOI · Paper page
- Gissen, 2015, Structural and functional hepatocyte polarity and liver disease, J. Hepatol., 63, 1023, 10.1016/j.jhep.2015.06.015 · DOI · Paper page
- Sharanek, 2016, Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs, Sci. Rep., 6, 24709, 10.1038/srep24709 · DOI · Paper page
- Yang, 2012, Cooperative activation of PI3K by Ras and Rho family small GTPases, Mol. Cell, 47, 281, 10.1016/j.molcel.2012.05.007 · DOI · Paper page
- Thenappan, 2010, Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver, Hepatology, 51, 1373, 10.1002/hep.23449 · DOI
- Guillemot, 2012, Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury, J. Cell Sci., 125, 5005
- Gunaratne, 2009, Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors, Hum. Pathol., 40, 783, 10.1016/j.humpath.2008.07.022 · DOI · Paper page
- Torre, 2011, Transcription dynamics in a physiological process: Beta-catenin signaling directs liver metabolic zonation, Int. J. Biochem. Cell Biol., 43, 271, 10.1016/j.biocel.2009.11.004 · DOI
- Hoekstra, 2011, The HepaRG cell line is suitable for bioartificial liver application, Int. J. Biochem. Cell Biol., 43, 1483, 10.1016/j.biocel.2011.06.011 · DOI
- Moedas, 2017, Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS, Anal. Biochem., 535, 47, 10.1016/j.ab.2017.07.025 · DOI
- Pernelle, 2011, Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye, Toxicol. Appl. Pharm., 254, 256, 10.1016/j.taap.2011.04.018 · DOI
- Xu, 2005, Induction of phase I, II and III drug metabolism/transport by xenobiotics, Arch. Pharm. Res., 28, 249, 10.1007/BF02977789 · DOI · Paper page
- Aninat, 2006, Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells, Drug Metab. Dispos., 34, 75, 10.1124/dmd.105.006759 · DOI · Paper page
- Wigger, L., Casals-Casas, C., Baruchet, M., Trang, K., Pradervand, S., Naldi, A., and Desvergne, B. (2019). System analysis of the functional cross-talk between PPARalpha, LXR and FXR in the human HepaRG liver cells. bioRxiv, 514976.
- Kanebratt, 2008, Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies, Drug Metab. Dispos., 36, 1444, 10.1124/dmd.107.020016 · DOI · Paper page
- Attignon, 2017, Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells, Arch. Toxicol., 91, 313, 10.1007/s00204-016-1700-4 · DOI
- Sarsour, 2014, Manganese superoxide dismutase regulates a redox cycle within the cell cycle, Antioxid. Redox Signal., 20, 1618, 10.1089/ars.2013.5303 · DOI
- Hu, 2014, Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver, Cell Cycle, 13, 2349, 10.4161/cc.29298 · DOI
- Gilot, 2002, Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation, J. Biol. Chem., 277, 49220, 10.1074/jbc.M207325200 · DOI
- Burban, 2017, Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways, Sci. Rep., 7, 1815, 10.1038/s41598-017-01171-y · DOI
- Madec, 2011, CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload, Drug Metab. Dispos., 39, 1987, 10.1124/dmd.110.036848 · DOI
- Samanez, 2012, The human hepatocyte cell lines IHH and HepaRG: Models to study glucose, lipid and lipoprotein metabolism, Arch. Physiol. Biochem., 118, 102, 10.3109/13813455.2012.683442 · DOI · Paper page
- Hijmans, 2014, Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences, Biochimie, 96, 121, 10.1016/j.biochi.2013.06.007 · DOI · Paper page
- Hall, 2014, USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy, Mol. Endocrinol., 28, 912, 10.1210/me.2013-1420 · DOI · Paper page
- Adachi, 2007, The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells, Gastroenterology, 132, 1434, 10.1053/j.gastro.2007.01.033 · DOI
- Parent, 2007, Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth, Cancer Res., 67, 4337, 10.1158/0008-5472.CAN-06-3640 · DOI
- Agrawal, 2014, DEPTOR is a stemness factor that regulates pluripotency of embryonic stem cells, J. Biol. Chem., 289, 31818, 10.1074/jbc.M114.565838 · DOI
- Ou, 2012, Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance, Endocrinology, 153, 2974, 10.1210/en.2011-2043 · DOI · Paper page
- Wagner, M., and Trauner, M. (2016). Recent advances in understanding and managing cholestasis. F1000Res, 5. · DOI
- Yang, 2010, Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice, Hepatology, 51, 1291, 10.1002/hep.23471 · DOI
- Sharanek, 2014, Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells, Toxicol. Sci., 141, 244, 10.1093/toxsci/kfu122 · DOI
- Dessalle, K., Euthine, V., Chanon, S., Delarichaudy, J., Fujii, I., Rome, S., Vidal, H., Nemoz, G., Simon, C., and Lefai, E. (2012). SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors. PLoS One, 7. · DOI · Paper page
Cited by
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65
Maseko, T., Elkalaf, M., Peterová, E., Lotková, H., Staňková, P., Melek, J., Dušek, J., Žádníková, P., Čížková, D., Bezrouk, A., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5342 · Cited by 21
Youhanna, S., Taebnia, N., Liang, Y., Cheng, N., Wang, Y., Michel, M., & Lauschke, V. M. (2025) · Advanced Biology · doi:10.1002/adbi.202500337 · Cited by 9
Metadata
- Authors
- Tascher, G., Burban, A., Camus, S., Plumel, M., Chanon, S., Le Guevel, R., Shevchenko, V., Van Dorsselaer, A., Lefai, E., Guguen-Guillouzo, C., & Bertile, F.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-02-21
- Volume
- 8
- Issue
- 2
- Pages
- 192
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2916303558
- Cited by
- 75
- References
- 9
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Seventh Framework Programme (267038)
- Cosmetics Europe (267038)
- French Proteomic Infrastructure (ProFI) (ANR-10-INSB-08-03)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.